$NVCN News

Last published 2y ago

2y agoBSX SOAR NVCNVolato Announces Changes to Board CompositionBusiness WireVolato to Announce First Quarter 2024 Results on Wednesday, May 15, 2024 Volato Group, Inc. ("Volato," or the "Company") (NYSE:SOAR) today announced that it has appointed Christopher G. Burger and Fred A. Colen to the
3y agoNVCNNeovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) today reported financial results for the fourth quarter and year ended
3y agoNVCNNeovasc Shareholders Approve Acquisition by Shockwave MedicalGlobeNewswireVANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), a leader in the development of minimally invasive devices for the
3y agoNVCNNeovasc Announces German Reimbursement RenewalGlobeNewswireVANCOUVER and MINNEAPOLIS, Feb. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or "the Company") (NASDAQ , TSX : NVCN) today announced the German Institute for the Hospital Remuneration System
3y agoANGN CNCE NVCN VLTAMoore Kuehn Encourages NVCN, VLTA, CNCE, and ANGN Investors to Contact Law FirmPR NewswireNEW YORK, Jan. 21, 2023 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following
3y agoNVCNShockwave Medical to Acquire NeovascGlobeNewswireVANCOUVER, BC, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN), a leader in the development of minimally invasive devices for the
3y agoNVCNNeovasc Announces Progress on COSIRA-II Clinical TrialGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced an update on the COSIRA-II Clinical Trial ("Trial") status.
3y agoNVCNNeovasc Comments on European Heart Journal PublicationGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case Reports has published an
4y agoNVCNNeovasc Announces Third Quarter Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) today reported financial results for the third quarter ended September 30,
4y agoNVCNNeovasc Reducer Obtains U.S. Outpatient ReimbursementGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the Centers for Medicare and Medicaid Services ("CMS")
4y agoNVCNNeovasc to Report Third Quarter Financial Results on November 10, 2022GlobeNewswireVANCOUVER and MINNEAPOLIS, Oct. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ , TSX : NVCN) will report financial results for the quarter ended September 30, 2022 on Thursday, November 10,
4y agoNVCNNeovasc Provides Corporate Update Following Clinical Data ReleaseGlobeNewswireNew Data Presented on the Neovasc Reducer™ in Patients With Microvascular Disease VANCOUVER and MINNEAPOLIS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) announced positive c
4y agoNVCNNeovasc to Participate in LSI Europe 2022 Emerging MedTech SummitGlobeNewswireVANCOUVER and MINNEAPOLIS, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the LSI Europe 2022 Emerging MedTech
4y agoNVCNNeovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory AnginaGlobeNewswireVANCOUVER and MINNEAPOLIS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today commented on the Centers for Medicare and Medicaid Services ("CMS") development of new codes for the
4y agoNVCNNeovasc Announces Key Events at TCT 2022GlobeNewswireVANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced its participation and presence at the Transcatheter Cardiovascular Therapeutics TCT 2022 co
4y agoNVCNNeovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, Aug. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright 24th Annual Global Inv
4y agoNVCNNeovasc Announces Second Quarter Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) today reported financial results for the second quarter ended June 30, 2022. Recent Highlights G
4y agoNVCNNeovasc to Report Second Quarter Financial Results on August 11, 2022GlobeNewswireVANCOUVER and MINNEAPOLIS, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ , TSX : NVCN), will report financial results for the quarter ended June 30, 2022 on Thursday, August 11, 2022. Neovasc's President and Chief Execut
4y agoNVCNNeovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsGlobeNewswireVANCOUVER and MINNEAPOLIS, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the United States Food and Drug Administration ("FDA") has approved a protocol supplement t
4y agoNVCNNeovasc Announces Direct Sales Operations in United KingdomGlobeNewswireExpansion Driven by NICE Guidelines and Enhanced Reimbursement for the Neovasc Reducer™ VANCOUVER and MINNEAPOLIS, July 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today annou
4y agoNVCNNeovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, June 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 Sidoti & Co. Summer Small C
4y agoNVCNNeovasc to Participate in H.C. Wainwright Global Investment ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, May 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ , TSX : NVCN) today announced that its management team will be participating in the H.C. Wainwright Global Investment C
4y agoNVCNNeovasc Regains Compliance with Nasdaq Minimum Bid Price RuleGlobeNewswireVANCOUVER and MINNEAPOLIS, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) announced today that it has received written notification from the Nasdaq Stock Market LLC (the "Nasdaq") inf
4y agoNVCNNeovasc Announces First Quarter Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, MN, May 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) today reported financial results for the quarter ended March 31, 2022. Recent Highlights · �
4y agoNVCNNeovasc to Report First Quarter Financial Results on May 12, 2022GlobeNewswireVANCOUVER and MINNEAPOLIS, MN, April 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (NASDAQ , TSX : NVCN), will report financial results for the quarter ended March 31, 2022 on Thursday, May 12, 2022. Neovasc's President and Chief
4y agoNVCNNeovasc Comments on European Heart Journal PublicationGlobeNewswireReport demonstrates objective improvements in patients suffering from microvascular dysfunction VANCOUVER and MINNEAPOLIS, April 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today an
4y agoNVCNNeovasc Announces Effective Date of Share ConsolidationGlobeNewswireVANCOUVER, BC, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the deve
4y agoNVCNNeovasc to Participate in Bloom Burton & Co. Healthcare Investment ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, April 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced that its management team will be participating in the 2022 Bloom Burton & Co. Healthc
4y agoNVCNNeovasc Inc. Reports Results of Annual General and Special Meeting of ShareholdersGlobeNewswireVANCOUVER, April 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) is pleased to announce the results of the votes on matters considered at its Annual General and Special Meeting of Sharehol
4y agoNVCNNeovasc Announces Consolidation and Extension of Convertible DebtGlobeNewswireVANCOUVER, BC, March 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN), a leader in the development of minimally invasive devices for the treatment of refractory angina, and in the devel
4y agoNVCNNeovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, March 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") ((NASDAQ, TSX:NVCN) today reported financial results for the fourth quarter and year ended December 31, 2021. Highlights
4y agoNVCNNeovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022GlobeNewswireVANCOUVER, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter and full year ended December 31, 2021 on Thursday, March 10, 2022. Neovasc's President and Chief Executive
4y agoNVCNNeovasc Announces German Reimbursement Renewal and Commercial ProgressGlobeNewswireVANCOUVER and MINNEAPOLIS, Feb. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the German Institute for the Hospital Remuneration System ("InEK") has awarded the Neovasc Re
4y agoNVCNIndependent Publication Reports Neovasc Reducer™ Demonstrates Cost SavingsGlobeNewswireVANCOUVER and MINNEAPOLIS, Feb. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of cost-effectiveness studies supporting the use of the Neovasc Reducer��
4y agoNVCNNeovasc Announces Publication Supporting the Neovasc Reducer™ DeviceGlobeNewswireVANCOUVER and MINNEAPOLIS, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, "The Effectiveness of CS Reducer for the Treatment o
4y agoNVCNNeovasc Announces Case Series of First U.S. Reducer Implants Published In Peer-Reviewed JournalGlobeNewswireVANCOUVER and MINNEAPOLIS, Jan. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicin
4y agoNVCNNeovasc to Participate in H.C. Wainwright BIOCONNECT Virtual ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, Jan. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2022 H.C. Wainwright BIOCONNECT Virtua
4y agoNVCNNeovasc Announces First Patient Enrollment in COSIRA-II TrialGlobeNewswireCOSIRA-II Trial Designed to Study the Neovasc Reducer™ for Patients with Refractory Angina VANCOUVER and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today an
4y agoACU ALCO ALOT AMST+60Sidoti December Micro Cap Virtual ConferenceACCESS NewswirePresentation Times Released for 75+ Presenting Companies Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / December 7, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day December Micro
4y agoNVCNNeovasc to Participate in Sidoti December Virtual Microcap ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, Dec. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that its management team will be participating in the Sidoti December Virtual Microcap Conf
4y agoNVCNNeovasc Reducer™ System Receives National Reimbursement in FranceGlobeNewswireFirst therapy to receive newly established French reimbursement designation VANCOUVER and MINNEAPOLIS, Nov. 30, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that t
4y agoNVCNNeovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price ComplianceGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") infor
4y agoNVCNThe National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer SystemGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the United Kingdom's Interventional Procedures Programme at the National Institut
5y agoNVCNNeovasc Announces Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewswireVANCOUVER and MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire --Neovasc, Inc.("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021. Third Quarte
5y agoACU ALCO ALOT AMST+57Sidoti Microcap Virtual ConferenceACCESS NewswireA Conference Open to All Classes of Investors70+ Companies Presenting and Meeting Interested Investors 1x1Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its preliminary list of
5y agoNVCNNeovasc to Report Third Quarter 2021 Financial Results on November 9, 2021GlobeNewswireVANCOUVER, Nov. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (NASDAQ, TSX: NVCN), will report financial results for the quarter ended September 30, 2021 on Tuesday, November 9, 2021. Neovasc's President and Chief Executive Officer Fr
5y agoNVCNEfficacy of the COronary SInus Reducer in Patients With Refractory Angina II - NCT05102019ClinicalTrials.govEffectiveness, Safety Events, Canadian Cardiovascular Society (CCS) Angina Score, Seattle Angina Questionnaire (SAQ) Score
5y agoNVCNNeovasc Reducer™ Featured in Polish Heart JournalGlobeNewswirePublication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today a
5y agoNVCNNeovasc REDUCER-I Study Published in EuroIntervention JournalGlobeNewswireVANCOUVER and MINNEAPOLIS, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, "Coronary sinus narrowing for the treatment of ref
5y agoNVCNNeovasc to Participate in 2021 Benzinga Healthcare Small Cap ConferenceGlobeNewswireVANCOUVER and MINNEAPOLIS, Sept. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ,TSX: NVCN) today announced that its management team will be participating in the 2021 Benzinga Healthcare Small Cap Co